Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Trimethoprim
Generic Name
Trimethoprim
Active Ingredient
TrimethoprimCategory
Sulfonamide Antimicrobial [EPC]
Variants
5
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Trimethoprim, you must consult a qualified healthcare professional.
| 100 mg/1 | TABLET | ORAL | 51407-738 |
| 100 mg/1 | TABLET | ORAL | 70954-541 |
Detailed information about Trimethoprim
Trimethoprim is a dihydrofolate reductase inhibitor antibacterial used primarily for the treatment and prophylaxis of urinary tract infections. It functions by disrupting bacterial folic acid synthesis, effectively halting bacterial replication.
The dosage of Trimethoprim is determined by the severity of the infection and the patient's renal function. For the treatment of acute, uncomplicated urinary tract infections, the standard adult dosage is:
Trimethoprim is used in pediatric patients primarily for the treatment of UTIs and occasionally for otitis media (middle ear infection).
Since Trimethoprim is primarily cleared by the kidneys, dosage adjustments are mandatory for patients with decreased renal function to prevent drug accumulation and toxicity.
While the liver plays a minor role in Trimethoprim metabolism, caution should be exercised in patients with severe hepatic dysfunction. No specific dosage adjustment formulas exist, but clinical monitoring for adverse effects is advised.
Geriatric patients often have age-related declines in renal function. Dosing should be initiated at the lower end of the range, and kidney function (serum creatinine) should be assessed before and during treatment. The risk of hyperkalemia (high potassium) is significantly higher in this population.
To ensure the best results and minimize side effects, follow these administration guidelines:
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up, as this increases the risk of side effects.
Acute overdose of Trimethoprim can lead to serious complications. Symptoms may include severe nausea, vomiting, dizziness, headache, mental depression, and confusion. Chronic overdosage (taking too much over a long period) can result in bone marrow depression, manifested as thrombocytopenia (low platelets) or leukopenia (low white blood cells).
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop the medication without medical guidance, as this can lead to treatment failure or antibiotic resistance.
Trimethoprim is generally well-tolerated, but some patients may experience mild to moderate side effects. The most frequently reported adverse reactions include:
Trimethoprim is a targeted antibiotic that requires careful clinical oversight. It is not effective against viral infections like the common cold or flu. Using antibiotics when they are not needed increases the risk of developing drug-resistant infections later. Patients should be screened for a history of folate deficiency and renal impairment before starting therapy.
No FDA black box warnings for Trimethoprim monotherapy. (Note: This differs from the combination product Trimethoprim-Sulfamethoxazole).
Trimethoprim must NEVER be used in the following circumstances:
Trimethoprim is classified as FDA Pregnancy Category C. It crosses the placenta and, due to its mechanism as a folate antagonist, there is a theoretical risk of causing birth defects, particularly neural tube defects (like spina bifida), if used during the first trimester.
Trimethoprim is excreted in human breast milk. While the amount an infant receives is generally low, the drug can interfere with the infant's folate metabolism.
Trimethoprim is a competitive inhibitor of bacterial dihydrofolate reductase (DHFR). Its molecular structure mimics the pteridine portion of dihydrofolic acid. By binding to the active site of the DHFR enzyme, Trimethoprim prevents the conversion of dihydrofolic acid to its active form, tetrahydrofolic acid. This inhibition is highly selective; the drug's affinity for bacterial DHFR is 100,000 times higher than its affinity for human DHFR. This block in the folate synthesis pathway prevents the bacteria from producing thymidine and purines, which are essential for DNA synthesis. Consequently, the bacteria cannot replicate, a state known as bacteriostatic inhibition.
The antibacterial activity of Trimethoprim is concentration-independent, meaning its efficacy is primarily related to the time the concentration remains above the Minimum Inhibitory Concentration (MIC) for the target pathogen. Resistance to Trimethoprim can develop through several mechanisms, including the acquisition of plasmids that code for altered DHFR enzymes with reduced drug affinity, or through the overproduction of the normal DHFR enzyme.
| Parameter | Value |
Common questions about Trimethoprim
Trimethoprim is an antibiotic primarily used to treat acute, uncomplicated urinary tract infections (UTIs) caused by susceptible bacteria such as E. coli. It works by preventing the bacteria from making the folic acid they need to grow and multiply. While it is most famous for its role in the combination drug Bactrim, it is also effective as a standalone treatment for bladder infections. Doctors may also prescribe it off-label for the long-term prevention of recurrent UTIs in people who get them frequently. It is only effective against bacterial infections and will not work for viral illnesses like the flu or the common cold.
The most common side effects reported by patients taking Trimethoprim include skin rashes, itching, and stomach-related issues like nausea or vomiting. Some people may also experience a strange or bitter taste in their mouth or a slightly sore tongue. These symptoms are usually mild and go away once the treatment is finished. However, if a rash appears, it is important to contact a healthcare provider immediately, as it could be the start of a more serious allergic reaction. Taking the medication with food can often help reduce the stomach upset associated with the drug.
There is no known direct dangerous interaction between alcohol and Trimethoprim, unlike some other antibiotics like metronidazole. However, healthcare providers generally recommend avoiding alcohol while fighting an infection because alcohol can dehydrate you and may suppress your immune system, potentially slowing down your recovery. Furthermore, chronic heavy alcohol use can lead to low folate levels in the body, which might increase the risk of blood-related side effects from Trimethoprim. It is best to stay well-hydrated with water to help flush the bacteria out of your urinary tract. Always consult your doctor for personalized advice regarding alcohol consumption during treatment.
Trimethoprim is generally avoided during the first trimester of pregnancy because it interferes with folic acid, which is crucial for the baby's spinal cord and brain development. Using it early in pregnancy has been linked to an increased risk of neural tube defects like spina bifida. In the second and third trimesters, it may be used if no other safer antibiotic options are available, but only under strict medical supervision. If you are pregnant or planning to become pregnant, you must inform your doctor so they can choose the safest treatment for your UTI. Most doctors prefer to use alternative antibiotics like nitrofurantoin or cephalexin during pregnancy.
Most patients begin to feel relief from UTI symptoms, such as burning during urination or frequent urges to go, within 24 to 48 hours of starting Trimethoprim. Even though you may feel better quickly, it is essential to finish the entire 10-day (or otherwise prescribed) course of the medication. Stopping the antibiotic too early can allow the strongest bacteria to survive and multiply, which can cause the infection to return or lead to antibiotic resistance. If your symptoms do not improve at all after three days of treatment, you should contact your healthcare provider to ensure the bacteria causing your infection are not resistant to the drug.
You can stop taking Trimethoprim suddenly once you have completed the full course prescribed by your doctor, as it does not cause withdrawal symptoms. However, you should never stop taking it in the middle of a treatment course just because you feel better. Doing so increases the risk that the infection will come back even stronger and may lead to the development of 'superbugs' that are resistant to antibiotics. The only reason to stop the medication early is if you experience a serious allergic reaction or a severe side effect, in which case you should seek medical advice immediately. Always follow the specific duration of therapy recommended by your healthcare professional.
If you miss a dose of Trimethoprim, you should take it as soon as you remember to maintain consistent levels of the antibiotic in your system. However, if it is almost time for your next scheduled dose, skip the missed one and continue with your regular dosing schedule. You should never take two doses at the same time to make up for a missed one, as this can increase the likelihood of side effects like nausea or skin rash. To help remember your doses, try taking the medication at the same time every day, such as with breakfast and dinner. Consistency is key to successfully clearing a bacterial infection.
Weight gain is not a recognized or common side effect of Trimethoprim. Because it is usually taken for a short duration (typically 10 days), it does not have the metabolic effects associated with long-term medications like steroids that cause weight changes. If you notice sudden weight gain or swelling (edema) while taking this medication, it could be a sign of a kidney problem or an allergic reaction rather than simple fat gain. In such cases, you should contact your doctor immediately. Most gastrointestinal side effects of Trimethoprim actually involve a decrease in appetite or nausea, which would more likely lead to temporary weight loss if anything.
Trimethoprim can interact with several other medications, some of which can be serious. It is particularly known to interact with blood thinners like warfarin, certain heart medications like digoxin, and drugs that increase potassium levels, such as ACE inhibitors (e.g., lisinopril). Taking these together can lead to dangerously high potassium levels or increased bleeding risks. It can also increase the toxicity of methotrexate, a drug used for cancer and rheumatoid arthritis. Because of these risks, you must provide your doctor and pharmacist with a complete list of all the prescriptions, over-the-counter drugs, and herbal supplements you are currently taking before starting Trimethoprim.
Yes, Trimethoprim is widely available as a generic medication, which makes it an affordable option for most patients. Generic versions are required by the FDA to have the same active ingredient, strength, dosage form, and route of administration as the original brand-name drug. In the past, it was sold under brand names like Primsol or Proloprim, but today, most pharmacies dispense the generic version. Because it has been on the market since 1980, the generic manufacturing process is well-established and highly regulated. Using the generic version is an effective way to treat your infection while keeping healthcare costs low.
While rare, certain side effects require urgent medical intervention.
> Warning: Stop taking Trimethoprim and call your doctor immediately if you experience any of these:
Prolonged use of Trimethoprim (for prophylaxis) can lead to certain chronic issues:
Currently, there are no FDA black box warnings specifically for Trimethoprim monotherapy. However, it is important to note that the combination product (Trimethoprim/Sulfamethoxazole) carries significant warnings regarding severe skin reactions and blood disorders, which patients should be aware of if they are switched between these medications.
Report any unusual symptoms or persistent side effects to your healthcare provider to ensure your treatment remains safe and effective.
If you are taking Trimethoprim for an extended period (more than two weeks) or have underlying health conditions, your healthcare provider may require the following tests:
Trimethoprim generally does not interfere with the ability to drive or operate heavy machinery. However, some patients may experience dizziness or headache as a side effect. If you feel dizzy or less alert than usual, avoid these activities until you know how the medication affects you.
There is no direct contraindication between Trimethoprim and alcohol. However, alcohol can dehydrate the body and weaken the immune system, which may slow the recovery from a urinary tract infection. Additionally, chronic alcohol use increases the risk of folate deficiency, which can exacerbate the hematologic side effects of Trimethoprim.
Unlike some medications for chronic conditions, Trimethoprim does not typically require a tapering schedule. However, it is critical not to stop the medication early just because symptoms disappear. Discontinuing the drug before the bacteria are fully eradicated can lead to a relapse of the infection and the development of antibiotic resistance.
> Important: Discuss all your medical conditions, especially kidney disease, liver disease, and any history of anemia, with your healthcare provider before starting Trimethoprim.
> Important: Tell your doctor about ALL medications, vitamins, supplements, and herbal products you are taking. A comprehensive review is necessary to prevent dangerous interactions.
Conditions requiring a careful risk-benefit analysis by a physician include:
While Trimethoprim is not a sulfonamide, it is often used with them. Patients who have had severe reactions to the combination product (Bactrim/Septra) must be evaluated to determine if the reaction was to the Trimethoprim component or the Sulfamethoxazole component. If the previous reaction was Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis, Trimethoprim should be avoided unless the cause is definitively known.
> Important: Your healthcare provider will evaluate your complete medical history, including any previous drug allergies or blood disorders, before prescribing Trimethoprim.
Trimethoprim is approved for use in children 2 months of age and older for the treatment of urinary tract infections. It is not approved for use in infants younger than 2 months due to the risk of interfering with folate-dependent growth processes. In older children, dosing is weight-based, and the liquid solution is preferred for accuracy. Long-term use in children requires monitoring of blood counts.
Elderly patients are at a significantly higher risk for adverse effects from Trimethoprim.
In patients with a Creatinine Clearance (CrCl) between 15 and 30 mL/min, the dose must be reduced by 50%. Trimethoprim is moderately dialyzable; therefore, for patients on hemodialysis, a supplemental dose may be required after the procedure. It is generally avoided in patients with a CrCl less than 15 mL/min due to the high risk of toxicity.
There are no standardized guidelines for Trimethoprim dosing in hepatic impairment. However, in patients with Child-Pugh Class C (severe) cirrhosis, the drug should be used with extreme caution. Monitoring for signs of liver injury, such as increased bilirubin or transaminases, is recommended during therapy.
> Important: Special populations require individualized medical assessment and frequent monitoring to ensure safety.
| Bioavailability | 90% - 100% |
| Protein Binding | 42% - 46% |
| Half-life | 8 - 11 hours (Adults) |
| Tmax | 1 - 4 hours |
| Metabolism | Hepatic (10-20%) via CYP enzymes |
| Excretion | Renal 80% (mostly unchanged), Fecal <5% |
Trimethoprim is classified as a Dihydrofolate Reductase Inhibitor Antibacterial. It is unique in that it targets the second step of the folate synthesis pathway. It is often grouped with sulfonamides (which target the first step) because they are frequently used together to achieve a sequential blockade of bacterial folate synthesis, resulting in potent synergistic activity.